Metabolic systems analysis of LPS induced endothelial dysfunction applied to sepsis patient stratification

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  McGarrity, Sarah ^a   Anuforo, Ósk ^a   Halldórsson, Haraldur ^a,b   Bergmann, Andreas ^a   Halldórsson, Skarphéinn ^a   Palsson, Sirus ^a   Henriksen, Hanne H ^c   Johansson, Pär Ingemar ^a,c   Rolfsson, Óttar ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 5-METHOXYTRYPTOPHAN; BIOLOGICAL MARKER; FATTY ACID; GAMMA INTERFERON; KYNURENINE; LIPOPOLYSACCHARIDE; LYSOPHOSPHOLIPID; NITRIC OXIDE; POLYSACCHARIDE; PROSTAGLANDIN D2; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE; TRYPTOPHAN;

BIOLOGICAL MODEL; BLOOD; CELL LINE; CHEMISTRY; CLASSIFICATION; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; GLYCOCALYX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METABOLISM; METABOLOME; MORTALITY; PATHOLOGY; PERMEABILITY; SEPSIS; SURVIVAL ANALYSIS; UMBILICAL VEIN ENDOTHELIAL CELL;

BIOMARKERS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDOTHELIAL CELLS; FATTY ACIDS; GAMMA-AMINOBUTYRIC ACID; GLYCOCALYX; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERFERON-GAMMA; KYNURENINE; LIPOPOLYSACCHARIDES; LYSOPHOSPHOLIPIDS; METABOLOME; MODELS, BIOLOGICAL; NITRIC OXIDE; PERMEABILITY; POLYSACCHARIDES; PROSTAGLANDIN D2; SEPSIS; SPHINGOSINE; SURVIVAL ANALYSIS; TRYPTOPHAN;

EID: 85046398805     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-25015-5     Document Type: Article

References (84)

1. Bone, R. et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101, 1644-1655 (1992).
2. Levy, M. et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 31, 1250-1256 (2003).
3. Singer, M. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315, 801 (2016).
4. Project, H. C. and U. http://www.hcup-us.ahrq.gov/reports/factsandfigures/2008/exhibit41.jsp.
5. Vincent, J.-L. et al. Sepsis in European Intensive Care Units: Results of the SOAP Study. Crit. Care Med. 34, 344-353 (2006).
6. Hawiger, J., Veach, R. &Zienkiewicz, J. New paradigms in sepsis: from prevention to protection of failing microcirculation. J. Thromb. Haemost (2015).
7. Liles, W. C. Special focus: endothelial activation/dysfunction. Virulence 4, 504-6 (2013).
8. Wang, B. et al. Correlation of lactate/albumin ratio level to organ failure and mortality in severe sepsis and septic shock. J. Crit. Care 30, 271-275 (2015).
9. Simmons, J. &Pittet, J.-F. The coagulopathy of acute sepsis. Curr. Opin. Anaesthesiol. 28, 227-36 (2015).
10. Ostrowski, S. S. R. et al. Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: a prospective study. Crit. Care Med. 19, 191 (2015).
11. Johansen, M. et al. Profound endothelial damage predicts impending organ failure and death in sepsis. Semin. Thromb. Hemost. 41, 16-25 (2015).
12. Schumer, W. Metabolism during shock and sepsis. Heart Lung 5, 416-21.
13. Mozaffarian, D. et al. Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation 133, 447-54 (2016).
14. Dellinger, R. et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit. Care Med. 41, 580-637 (2013).
15. Langley, R. J. et al. An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci. Transl. Med. 5, 195ra95 (2013).
16. Steelman, S. M., Johnson, P., Jackson, A., Schulze, J. &Chowdhary, B. P. Serum metabolomics identifies citrulline as a predictor of adverse outcomes in an equine model of gut-derived sepsis. Physiol. Genomics 46, 339-47 (2014).
17. Kamisoglu, K. et al. Human metabolic response to systemic inflammation: assessment of the concordance between experimental endotoxemia and clinical cases of sepsis/SIRS. Crit. Care 19, 71 (2015).
18. Kamisoglu, K. K. et al. Temporal metabolic profiling of plasma during endotoxemia in humans. Shock 40, 519-526 (2013).
19. Sikorski, K. et al. STAT1-mediated signal integration between IFNγ and LPS leads to increased EC and SMC activation and monocyte adhesion. Am. J. Physiol.-Cell Physiol. 300 (2011).
20. Eelen, G., de Zeeuw, P., Simons, M. &Carmeliet, P. Endothelial Cell Metabolism in Normal and Diseased Vasculature. Circ. Res. 116, 1231-1244 (2015).
21. Wautier, J.-L. &Schmidt, A. M. Protein glycation: a firm link to endothelial cell dysfunction. Circ. Res. 95, 233-8 (2004).
22. Patella, F. et al. Proteomics-Based Metabolic Modeling Reveals That Fatty Acid Oxidation (FAO) Controls Endothelial Cell (EC) Permeability. Mol. Cell. Proteomics 14, 621-634 (2015).
23. Bruegel, M. et al. Sepsis-associated changes of the arachidonic acid metabolism and their diagnostic potential in septic patients. Crit. Care Med. 40, 1478-86 (2012).
24. Coldewey, S. M. et al. Elevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsis. Sci. Rep. 6, 27594 (2016).
25. Winkler, M. S. et al. Decreased serum concentrations of sphingosine-1-phosphate in sepsis. Crit. Care 19, 372 (2015).
26. Changsirivathanathamrong, D. et al. Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis. Crit. Care Med. 39, 2678-83 (2011).
27. Wang, Y.-F. et al. Endothelium-Derived 5-Methoxytryptophan Is a Circulating Anti-Inflammatory Molecule That Blocks Systemic InflammationNovelty and Significance. Circ. Res. 119, 222-236 (2016).
28. Ware, L. B. et al. Low plasma citrulline levels are associated with acute respiratory distress syndrome in patients with severe sepsis. Crit. Care 17, R10 (2013).
29. Cohen, J. et al. Sepsis: a roadmap for future research. Lancet 15, 581-614 (2015).
30. Bordbar, A., Monk, J., King, Z. &Palsson, B. Constraint-based models predict metabolic and associated cellular functions. Nat. Rev. Genet. 15, 107-120 (2014).
31. Stempler, S., Yizhak, K. &Ruppin, E. Integrating transcriptomics with metabolic modeling predicts biomarkers and drug targets for Alzheimer's disease. PLoS One 9, e105383 (2014).
32. Mardinoglu, A. et al. Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol. Syst. Biol. 9, 649 (2013).
33. Björnson, E. et al. Stratification of Hepatocellular Carcinoma Patients Based on Acetate Utilization. Cell Rep. 13, 2014-2026 (2015).
34. Thiele, I. &Palsson, B. A protocol for generating a high-quality genome-scale metabolic reconstruction. Nat. Protoc. 5, 93-121 (2010).
35. Liu, Z., Yin, P., Amathieu, R., Savarin, P. &Xu, G. Application of LC-MS-based metabolomics method in differentiating septic survivors from non-survivors. Anal. Bioanal. Chem. 408, 7641-7649 (2016).
36. Wang, Y. et al. Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat. Med. 16, 279-85 (2010).
37. Venkataraman, K. et al. Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate. Circ. Res. 102 (2008).
38. Sen, S. et al. γ-Aminobutyric Acid Is Synthesized and Released by the EndotheliumNovelty and Significance. Circ. Res. 119, 621-634 (2016).
39. Urquhart, P., Parkin, S. M. &Nicolaou, A. Profile of eicosanoids produced by human saphenous vein endothelial cells and the effect of dietary fatty acids. Prostaglandins, Leukot. Essent. Fat. Acids 65, 15-22 (2001).
40. Pasaoglu, O. T. et al. The Effect of Taurine on the Relationship Between NO, ADMA and Homocysteine in Endotoxin-Mediated Inflammation in HUVEC Cultures. Inflammation 37, 1439-1443 (2014).
41. Schoors, S. et al. Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature 520, 192-7 (2015).
42. Duarte, N. et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data. PNAS 104, 1777-1782 (2007).
43. Feist, A. M. &Palsson, B. O. The biomass objective function. Curr. Opin. Microbiol. 13, 344-349 (2010).
44. Wiesinger, A. et al. Nanomechanics of the Endothelial Glycocalyx in Experimental Sepsis. PLoS One 8, e80905 (2013).
45. Rau, C.-S. et al. Lipopolysaccharide-induced microRNA-146a targets CARD10 and regulates angiogenesis in human umbilical vein endothelial cells. Toxicol. Sci. 140, 315-26 (2014).
46. Darcy, C. J. et al. An Observational Cohort Study of the Kynurenine to Tryptophan Ratio in Sepsis: Association with Impaired Immune and Microvascular Function. PLoS One 6, e21185 (2011).
47. Dalli, J. et al. Human Sepsis Eicosanoid and Proresolving Lipid Mediator Temporal Profiles: Correlations With Survival and Clinical Outcomes. Crit. Care Med. 45, 58-68 (2017).
48. AIRD, W. C. Spatial and temporal dynamics of the endothelium. J. Thromb. Haemost. 3, 1392-1406 (2005).
49. Cheng, H.-H. et al. Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan. Proc. Natl. Acad. Sci. 109, 13231-13236 (2012).
50. Sun, X. et al. Functional promoter variants in sphingosine 1-phosphate receptor 3 associate with susceptibility to sepsis-associated acute respiratory distress syndrome. Am. J. Physiol. Lung Cell. Mol. Physiol. 305, L467-77 (2013).
51. Zhang, G. et al. Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation. Blood 122, 443-55 (2013).
52. Sun, X. et al. Sphingosine-1-Phosphate Receptor-3 Is a Novel Biomarker in Acute Lung Injury. Am. J. Respir. Cell Mol. Biol. 47, 628-636 (2012).
53. Mahajan-Thakur, S., Böhm, A., Jedlitschky, G., Schrör, K. &Rauch, B. H. Sphingosine-1-Phosphate and Its Receptors: A Mutual Link between Blood Coagulation and Inflammation. Mediators Inflamm. 2015, 831059 (2015).
54. Bhasin, M. et al. Bioinformatic identification and characterization of human endothelial cell-restricted genes. BMC Genomics 11, 342 (2010).
55. Steppan, J. et al. Sepsis and Major Abdominal Surgery Lead to Flaking of the Endothelial Glycocalix. J. Surg. Res. 165, 136-141 (2011).
56. Su, L. et al. Identification of Novel Biomarkers for Sepsis Prognosis via Urinary Proteomic Analysis Using iTRAQ Labeling and 2D-LC-MS/MS. PLoS One 8, e54237 (2013).
57. Puskarich, M. A., Cornelius, D. C., Tharp, J., Nandi, U. &Jones, A. E. Plasma syndecan-1 levels identify a cohort of patients with severe sepsis at high risk for intubation after large-volume intravenous fluid resuscitation. J. Crit. Care 36, 125-129 (2016).
58. Wilkerson, B. A. &Argraves, K. M. The role of sphingosine-1-phosphate in endothelial barrier function. Biochim. Biophys. Acta-Mol. Cell Biol. Lipids 1841, 1403-1412 (2014).
59. Zeden, J.-P. et al. Excessive tryptophan catabolism in septic patients: Anaesthesia and Intensive Care Journal. Anaesth. Intensive Care 38.
60. Ojeda, M. et al. Temporal trends of circulating nitric oxide and pro-inflammatory cytokine responses ex vivo in intra-abdominal sepsis: results from a cohort study. Inflamm. Res. 60, 289-297 (2011).
61. Kriehuber, E. et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J. Exp. Med. 194, 797-808 (2001).
62. Halldórsson, H., Thors, B. &Thorgeirsson, G. Thrombin or Ca++-Ionophore-Mediated Fall in Endothelial ATP Levels Independent of Poly(ADP-Ribose) Polymerase Activity and NAD Levels-Comparison with the Effects of Hydrogen Peroxide. Nucleosides, Nucleotides and Nucleic Acids 34, 246-257 (2015).
63. Jaffe, E. A., Nachman, R. L., Becker, C. G. &Minick, C. R. Culture of Human Endothelial Cells Derived from Umbilical Veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52, 2745-2756 (1973).
64. Paglia, G. et al. Intracellular metabolite profiling of platelets: Evaluation of extraction processes and chromatographic strategies. J. Chromatogr. B 898, 111-120 (2012).
65. Xia, J., Wishart, D. S., Xia, J. &Wishart, D. S. In Current Protocols in Bioinformatics 14.10.1-14.10.91 https://doi.org/10.1002/cpbi.11 (John Wiley &Sons, Inc., 2016).
66. Edelstein, A. D. et al. Advanced methods of microscope control using μManager software. J. Biol. Methods 1, 10 (2014).
67. Schneider, C. A., Rasband, W. S. &Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671-675 (2012).
68. Yuan, S. Y. &Rigor, R. R. Methods for Measuring Permeability (2010).
69. EBI, Bhasin, B. &Oettgen, P. http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-21212/.
70. Kolesnikov, N. et al. ArrayExpress update-simplifying data submissions. Nucleic Acids Res. 43, D1113-6 (2015).
71. Vlassis, N., Pacheco, M. P., Sauter, T., Miller, J. &Kisters-Woike, B. Fast Reconstruction of Compact Context-Specific Metabolic Network Models. PLoS Comput. Biol. 10, e1003424 (2014).
72. Thiele, I. et al. A community-driven global reconstruction of human metabolism. Nat. Biotechnol. 31, 419-425 (2013).
73. Schellenberger, J. et al. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0. Nat. Protoc. 6, 1290-1307 (2011).
74. Dennis, G. et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4, P3 (2003).
75. Huang, D. W., Sherman, B. T. &Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009).
76. E-GEOD-50619 Browse ArrayExpress EMBL-EBI. at https://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-50619/.
77. Su, L. et al. Dynamic changes in amino acid concentration profiles in patients with sepsis. PLoS One 10, e0121933 (2015).
78. Su, L. et al. Discrimination of sepsis stage metabolic profiles with an LC/MS-MS-based metabolomics approach. BMJ open Respir. Res. 1, e000056 (2014).
79. Orth, J., Thiele, I. &Palsson, B. What is flux balance analysis? Nat. Biotechnol. 28, 245-248 (2010).
80. Chen, H. &Boutros, P. CRAN-Package VennDiagram. at https://cran.r-project.org/web/packages/VennDiagram/index.html (2011).
81. Lemon, J. Plotrix: a package in the red light district of R. R-News 6, 8-12 (2006).
82. Wickham, H. ggplot2: Elegant Graphics for Data Analysis. (2009).
83. Javanmard, S. H. &Dana, N. The effect of interferon γ on endothelial cell nitric oxide production and apoptosis. Adv. Biomed. Res. 1, 69 (2012).
84. Lekkou, A. et al. Serum lipid profile, cytokine production, and clinical outcome in patients with severe sepsis. J. Crit. Care 29, 723-727 (2014).